Skip to content

PolitiKit

Lobbying by Viotika Life Sciences Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

Viotika Life Sciences Inc.

Meetings this Parliament
0
With MPs
0
Since Nov 2021
1
Active registrations
1

Most recent reported meeting: May 23, 2024.

Registrations in effect

Consultant In effect since May 20, 2024

Consultant Bruce Hartley of Prospectus Associates in Corporate Development

Consultant lobbyists

  • Bruce Hartley Former public office holder

    Formerly Executive Assistant to the Prime Minister, Prime Minister's Office, Prime Minister's Office (1995–2003)

    Formerly Legislative Assistant to the Prime Minister, Prime Minister's Office, Prime Minister's Office (1993–1995)

Institutions they may lobby: Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), National Research Council (NRC), Prime Minister's Office (PMO), Privy Council Office (PCO), Senate of Canada

What they're lobbying on (1)
  • Seeking life sciences funding opportunities from the Government of Canada to advance novel research in pursuit of a solution to the escalating global crisis of antimicrobial resistance (AMR).

Registration 776913-378223-1. Look it up in the official Registry

Reported meetings

Spreadsheet

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.